Abstract
Eukaryotic protein kinases (EPKs) adopt an active conformation following phosphorylation of a particular activation loop residue. Most EPKs spontaneously autophosphorylate this residue. While structure–function relationships of the active conformation are essentially understood, those of the “prone-to-autophosphorylate” conformation are unclear. Here, we propose that a site within the αC-helix of EPKs, occupied by Arg in the mitogen-activated protein kinase (MAPK) Erk1/2 (Arg84/65), impacts spontaneous autophosphorylation. MAPKs lack spontaneous autoactivation, but we found that converting Arg84/65 of Erk1/2 to various residues enables spontaneous autophosphorylation. Furthermore, Erk1 molecules mutated in Arg84 are oncogenic. Arg84/65 thus obstructs the adoption of the “prone-to-autophosphorylate” conformation. All MAPKs harbor an Arg that is equivalent to Arg84/65 of Erks, whereas Arg is rarely found at the equivalent position in other EPKs. We observed that Arg84/65 of Erk1/2 interacts with the DFG motif, suggesting that autophosphorylation may be inhibited by the Arg84/65–DFG interactions. Erk1/2s mutated in Arg84/65 autophosphorylate not only the TEY motif, known as critical for catalysis, but also on Thr207/188. Our MS/MS analysis revealed that a large proportion of the Erk2R65H population is phosphorylated on Thr188 or on Tyr185 + Thr188, and a small fraction is phosphorylated on the TEY motif. No molecules phosphorylated on Thr183 + Thr188 were detected. Thus, phosphorylation of Thr183 and Thr188 is mutually exclusive suggesting that not only TEY-phosphorylated molecules are active but perhaps also those phosphorylated on Tyr185 + Thr188. The effect of mutating Arg84/65 may mimic a physiological scenario in which allosteric effectors cause Erk1/2 activation by autophosphorylation.
Original language | English |
---|---|
Article number | 105072 |
Journal | Journal of Biological Chemistry |
Volume | 299 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors
Funding
We thank Dr Allan Bar-Sinai and Prof Shlomo Sasson for useful comments on the article. We acknowledge The De Botton Protein Profiling institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine for performing the MS/MS experiments. We thank Dr Alon Savidor for helping in analyzing the MS data. N. S. and D. E. conceptualization; N. S. A. B. K. S.-A. J. B. R. H. O. L. and R. I. methodology; A. B. formal analysis; N. S. A. B. J. B. Y. G. R. H. M. A. and D. E. investigation; N. S. A. B. R. I. and D. E. writing–original draft. The study was supported by the Israel Science Foundation, grant 1463/18 (to D. E.), the Israel Cancer Association (to D. E.), and the Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence and Technology Enterprise (to D. E.). D. E. holds a Wolfson family chair in Biochemistry. N. S. is a fellow of the Arianne de Rothschild Women Doctoral Program. The study was supported by the Israel Science Foundation , grant 1463/18 (to D. E.), the Israel Cancer Association (to D. E.), and the Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence and Technology Enterprise (to D. E.). D. E. holds a Wolfson family chair in Biochemistry. N. S. is a fellow of the Arianne de Rothschild Women Doctoral Program.
Funders | Funder number |
---|---|
Arianne de Rothschild Women Doctoral Program | |
Wolfson family chair in Biochemistry | |
National Research Foundation Singapore | |
Israel Cancer Association | |
Israel Science Foundation | 1463/18 |
Keywords
- ERK
- MAP kinase
- activation loop
- active variants
- autophosphorylation
- eukaryotic protein kinases